Cytek Biosciences Inc (FRA:8EQ)
€ 3.8 -0.10 (-2.56%) Market Cap: 523.92 Mil Enterprise Value: 317.79 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 71/100

Cytek Biosciences Inc Annual Shareholders Meeting Transcript

Jun 10, 2026 / 06:00PM GMT
Release Date Price: €3.5 (+9.38%)
Wenbin Jiang
Cytek Biosciences Inc - Chairman of the Board, President, Chief Executive Officer, Co-Founder

Good morning, ladies and gentlemen. I am Wenbin Jiang, President and Chief Executive Officer of Cytek Biosciences. It is a pleasure to welcome you to Cytek's 2026 Annual Meeting of Stockholders. I'd also like to welcome the company directors who are with us today, including Vera Imper and Richard Chin. Director Nominee Glenn P. Muir is also on the line.

Also present are Tammy Wang, the company's Deputy General Counsel; William McCombe, the company's Chief Financial Officer; and Paul Goodson, the company's Head of Investor Relations.

May be from our auditors, Deloy and touché, who are available to respond to appropriate questions.

Protocol, our external legal counsel from Cooley and Richard L. Lieser Jr., our inspector of election for the meeting.

Everyone will record the minutes of this meeting.

This annual meeting is being held in accordance with the company's bylaws and delaware laws.

We will begin today with the formal business of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot